Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03303404 · ClinicalTrials.gov registry record · NA
24-hour Blood Pressure Measurements and Ischemic Conditioning
A NA study, sponsored by University of Texas at Austin.
- Completed
- Registry status
- NA
- Development phase
- 22
- Enrollment target
NCT03303404 is a NA study that has completed, run by University of Texas at Austin. The registered enrollment target is 22 participants.
The verdict
NCT03303404, a NA study, has completed, sponsored by University of Texas at Austin.
- COMPLETED
- Registry status
- NA
- Development phase
- 22 participants
- Enrollment target
Study Summary
To determine if 24-hr ambulatory blood pressure monitoring effects endothelial function, we will measure flow-mediated dilation before and after the blood pressure monitoring (ischemia conditioning).
Interventions
- DEVICE Ambulatory (24-hour) Blood Pressure
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2017-09-12 |
| Est. Completion | 2018-09-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03303404
The ClinicalTrials.gov registry entry for NCT03303404 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas at Austin, which has 257 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Ambulatory (24-hour) Blood Pressure is the first listed.
NCT03303404 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03303404 about?
NCT03303404 is a clinical study titled "24-hour Blood Pressure Measurements and Ischemic Conditioning". To determine if 24-hr ambulatory blood pressure monitoring effects endothelial function, we will measure flow-mediated dilation before and after the blood pressure monitoring (ischemia conditioning).
What is the current status of trial NCT03303404?
This trial is currently completed. It is a NA study. The enrollment target is 22 participants. The study started on 2017-09-12. Estimated completion is 2018-09-20.
What interventions are being tested in trial NCT03303404?
The interventions under investigation include: Ambulatory (24-hour) Blood Pressure (DEVICE).
Who is sponsoring clinical trial NCT03303404?
This trial is sponsored by University of Texas at Austin, which has 257 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.